332 related articles for article (PubMed ID: 6455174)
21. Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate.
Smith FW; Gilday DL; Ash JM; Reid RH
Radiology; 1980 Nov; 137(2):501-4. PubMed ID: 6449027
[TBL] [Abstract][Full Text] [Related]
22. [Extraosseous nuclide uptake during skeletal scintigraphy. Heparin-calcium-induced 99mTc-HMDP accumulation].
Baum RP; Brandhorst I; Maul FD; Hör G
Rofo; 1985 Aug; 143(2):247-9. PubMed ID: 2992051
[No Abstract] [Full Text] [Related]
23. [Accumulation of sodium 2,3-dicarboxypropan-1,1-diphosphonate in bone of rabbits (author's transl)].
Nagai K; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Muranaka A; Ito Y
Radioisotopes; 1982 Apr; 31(4):197-8. PubMed ID: 6213983
[No Abstract] [Full Text] [Related]
24. [Bone scintigraphy with Tc-99m methylene diphosphonate: a comparison with ethane-hydroxy-diphosphonate (author's transl)].
Nakano S; Hasegawa Y; Shiomura K; Ibuka K
Kaku Igaku; 1978 Jun; 15(4):587-90. PubMed ID: 100638
[No Abstract] [Full Text] [Related]
25. What do we want from a bone-scanning agent?
Fogelman I; Bessent RG
J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
[No Abstract] [Full Text] [Related]
26. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.
Hommeyer SH; Varney DM; Eary JF
J Nucl Med; 1992 May; 33(5):748-50. PubMed ID: 1569485
[TBL] [Abstract][Full Text] [Related]
27. [Extraosseous accumulation of 99m-Tc-MDP--with special reference to intratumor accumulation].
Yasuda E; Yoshida H; Ichikawa H; Matsuo S; Kimura T; Kanamori I; Nakano S; Watahiki H; Takeda I
Rinsho Hoshasen; 1983 Aug; 28(8):851-7. PubMed ID: 6228679
[No Abstract] [Full Text] [Related]
28. [Horseshoe kidney incidentally detected by 99mTc-MDP bone scintigraphy: report of 2 cases (author's transl)].
Bussaka H; Takahashi M
Rinsho Hoshasen; 1982 May; 27(5):581-3. PubMed ID: 6213796
[No Abstract] [Full Text] [Related]
29. [Value and limitations of scintigraphy based on methylene diphosphonate pyrophosphate labeled with 99m technetium in the monitoring of revascularized bone transplants].
Clouet M; Chavoin JP; Vigoni F; Pessey JJ; Costagliola M
Ann Chir Plast; 1981; 26(3):217-20. PubMed ID: 6458230
[No Abstract] [Full Text] [Related]
30. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
Rudd TG; Allen DR; Smith FD
J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
[TBL] [Abstract][Full Text] [Related]
31. Studies of skeletal tracer kinetics. III. Tc-99m(Sn)methylenediphosphonate uptake in the canine tibia as a function of blood flow.
Sagar VV; Piccone JM; Charkes ND
J Nucl Med; 1979 Dec; 20(12):1257-61. PubMed ID: 536792
[TBL] [Abstract][Full Text] [Related]
32. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.
Rosenthall L; Arzoumanian A; Damtew BU; Tremblay J
Clin Nucl Med; 1981 Aug; 6(8):353-5. PubMed ID: 6455231
[No Abstract] [Full Text] [Related]
33. The effect of methylene diphosphonate on the tissue distribution of gallium-67.
Downing D; Aburano T; Bushberg J; Hoffer PB
J Nucl Med; 1985 Oct; 26(10):1202-5. PubMed ID: 3862767
[TBL] [Abstract][Full Text] [Related]
34. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
Pauwels EK; Camps JA; Blom J; Hermans J; Kelly JD; Cumming SA; Blackburn GM; Rashid A
Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
[TBL] [Abstract][Full Text] [Related]
36. Transient accumulation of Tc 99m MDP in the liver.
Dudczak R; Angelberger P; Kletter K; Frischauf H
Eur J Nucl Med; 1980 Apr; 5(2):189-91. PubMed ID: 6445828
[TBL] [Abstract][Full Text] [Related]
37. A clinical comparison of Tc-99m HEDP and Tc-99m MDP.
Coupal JJ; Kim EE
J Nucl Med; 1979 Aug; 20(8):896-7. PubMed ID: 120424
[No Abstract] [Full Text] [Related]
38. Factors influencing the distribution of 99m-technetium methylene diphosphonate in bone and soft tissues.
Khan RA
Experientia; 1978 Dec; 34(12):1598-600. PubMed ID: 32068
[TBL] [Abstract][Full Text] [Related]
39. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
40. Increased renal uptake of [99mTc]methylene diphosphonate.
Lin DS; Sanders JA; Flowers WM
Int J Nucl Med Biol; 1982; 9(3):201-7. PubMed ID: 6215374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
